Salicylic acid

Description

MAXIMUM STRENGTH WART REMOVER LIQUID is a topical formulation designed for the removal of warts. This product is presented in liquid form, allowing for direct application to affected areas. The effective date for this product is established as December 31, 2024.

Uses and Indications

This drug is indicated for the removal of warts, including plantar warts, flat warts, common warts, as well as corns and calluses. Plantar warts are specifically characterized by their location on the bottom of the foot, tenderness upon pressure, and disruption of the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. It is recommended to soak the wart in warm water for approximately 5 minutes to facilitate the removal process. After soaking, the area must be dried completely.

Using an applicator, such as a cotton swab, a layer of ointment should be applied to sufficiently cover each wart. It is important to allow the ointment to fully absorb into the skin. If necessary, the treated area may be covered with a bandage to protect it.

This procedure should be repeated once or twice daily as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in individuals with a known allergy to any of its ingredients. Additionally, it should not be used during pregnancy or breastfeeding due to potential risks to the mother and child.

The product is also contraindicated for application on damaged skin, including areas with cuts, abrasions, eczema, or sunburn, as this may exacerbate irritation or lead to adverse effects.

Warnings and Precautions

The liquid formulation is prone to volatilization and crystallization; therefore, it is imperative to securely tighten the cap after each use to maintain its integrity. Prolonged exposure to air should be avoided to ensure optimal efficacy.

This product is intended for external use only. It must not come into contact with the eyes or be ingested. Children should utilize this product only under the supervision of an adult to prevent accidental ingestion or misuse.

In the event of accidental ingestion, immediate medical assistance should be sought. Contact a Poison Control Center or seek emergency medical help without delay.

Patients are advised to discontinue use and consult a healthcare professional if they experience any adverse reactions or if there is a suspicion of a more serious skin condition. Prompt medical evaluation is essential in such cases to ensure appropriate management.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. The liquid formulation is prone to volatilization and crystallization; therefore, it is crucial to tighten the cap securely after each use to maintain its integrity. Long-term exposure to air should be avoided to prevent degradation of the product.

This product is intended for external use only. Patients must take care to avoid contact with the eyes and should not ingest the product. It is recommended that children use this product under the supervision of adults to ensure safety.

In the event of adverse reactions, patients are advised to consult a healthcare professional, as they may be experiencing a more serious skin condition that requires medical attention.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Maximum Strength Wart Remover. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this product under the supervision of adults to ensure safety and proper administration. It is crucial to keep the product out of reach of children to prevent accidental ingestion. In the event of swallowing, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this medication. The potential risks associated with the use of this drug during pregnancy have not been established, and its safety profile in lactating women is also unclear. Therefore, healthcare professionals are advised to counsel women of childbearing potential regarding the importance of effective contraception during treatment and to avoid use in pregnancy and breastfeeding to prevent any potential adverse fetal outcomes.

Lactation

Lactating mothers are advised against the use of this medication. There is no available data on the excretion of the drug in human breast milk or its effects on breastfed infants. Therefore, due to the lack of safety information, breastfeeding is not recommended while using this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

There is no information available regarding hepatic impairment, including dosage adjustments, special monitoring, or precautions for patients with compromised liver function. Therefore, no specific recommendations can be made for the use of this medication in patients with hepatic impairment. It is advised that healthcare professionals exercise caution and consider individual patient circumstances when prescribing this medication to patients with liver problems.

Overdosage

In the context of overdosage, there is currently no specific information available regarding the effects or management of an overdose for this medication. Healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse reactions that may arise.

In the absence of detailed overdosage data, it is recommended that standard supportive measures be employed. This includes ensuring the patient's safety, providing symptomatic treatment, and considering the use of activated charcoal if the ingestion occurred within a timeframe that warrants its use.

Healthcare providers should remain vigilant and report any observed adverse effects to the appropriate regulatory authorities to contribute to the ongoing assessment of the medication's safety profile.

Nonclinical Toxicology

The use of this product is contraindicated in pregnant or breastfeeding individuals due to potential teratogenic effects. No additional non-teratogenic effects have been reported in the available data. Furthermore, there is no information provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product on damaged skin, including areas with cuts, abrasions, eczema, or sunburn, as this may exacerbate their condition. Additionally, it is important to counsel patients against using the product if they have a known allergy to any of its ingredients.

Healthcare providers should also emphasize that the product should not be used during pregnancy or while breastfeeding. Patients should be encouraged to consult a doctor if they suspect they may have a more serious skin condition, as this may require alternative treatment options.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It is essential to store the product at a temperature range of 68°F to 77°F (20°C to 25°C). Care should be taken to protect the product from excessive heat, specifically temperatures exceeding 104°F (40°C). Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Maximum Strength Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)